Japan Change of Control

Within the year Japan will oversee all US ONC business and will drive strategy while AZ works on execution, sales, contracting and marketing. DSI will step away from all customer interfacing activities

 

Slated for 2/21

 

Sai and Antoine have both said, privately, this will happen Q1 of next year

 

Someone from finance must leak this, there’s been a small group working on this and it is planned for 2021 but the date hasn’t been set. ONC will still be DSI but run out of Japan and Antoine not US commercial

 

so, what does that mean for sales force?? Will iron be laid off then

 

no INJ is unrelated, questions are more around label change and new competition and sales decline, that will be managed separately though

 

They’re already anticipating decline for new onc drug?!? Do tell.

 

not correct they will move oversight to a new Global ONC BU and that will be overseen by a new leadership group between Japan and AY’s team. there could be some consolidation but too early to say until sales are seen, your leaders will change

 

short story is KW, Dan. TW, KS, K4, TL, BH, KR are all expensive overhead and will be out, only Simon stays

 

Internal team will be gone, done deal. There will be a global oncology business with regional components and Antoine will lead US and will be using his own team. Some adjustments to our field but too early to say but DSI leaders will be no more

 

Heard it from people on the project that oncology business will be run by a global group in Japan.

r and d remains the same . They will ask most of region business leaders to leave at end of this fiscal year. And eliminate most of regional org . Having just a sales team that will report to a global group. Expect moves to happen in next few months.

 

fat severance checks and continual stock appreciation based off 8201 for those who offered no value... Corporate America continues to be one hell of a place

 

severance policy was changed, see our SEC filings, no more fat checks Holmes

 

New competitor is more of a threat on the Hospital only space

 

And so the cuts begin.

 

Lixiana price cut came out today, a really huge financial hit for us

 

Slow sales and reductions are accelerating are job cuts

 

price cut was 25%!